Enovis EPS - Earnings per Share 2010-2024 | ENOV
Enovis eps - earnings per share from 2010 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Enovis Annual EPS | |
|---|---|
| 2023 | $-0.61 |
| 2022 | $-0.25 |
| 2021 | $1.40 |
| 2020 | $0.93 |
| 2019 | $-11.67 |
| 2018 | $3.48 |
| 2017 | $3.66 |
| 2016 | $3.12 |
| 2015 | $4.02 |
| 2014 | $9.06 |
| 2013 | $4.62 |
| 2012 | $-2.76 |
| 2011 | $0.30 |
| 2010 | $1.11 |
| 2009 | $1.65 |
| Enovis Quarterly EPS | |
|---|---|
| 2024-09-30 | $-0.58 |
| 2024-06-30 | $-0.34 |
| 2024-03-31 | $-1.32 |
| 2023-12-31 | $0.05 |
| 2023-09-30 | $-0.05 |
| 2023-06-30 | $-0.18 |
| 2023-03-31 | $-0.43 |
| 2022-12-31 | $-0.71 |
| 2022-09-30 | $-1.23 |
| 2022-06-30 | $1.41 |
| 2022-03-31 | $0.28 |
| 2021-12-31 | $-0.05 |
| 2021-09-30 | $0.49 |
| 2021-06-30 | $0.56 |
| 2021-03-31 | $0.40 |
| 2020-12-31 | $0.72 |
| 2020-09-30 | $0.30 |
| 2020-06-30 | $-0.18 |
| 2020-03-31 | $0.09 |
| 2019-12-31 | $-0.39 |
| 2019-09-30 | $0.24 |
| 2019-06-30 | $-10.35 |
| 2019-03-31 | $-1.17 |
| 2018-12-31 | $1.17 |
| 2018-09-30 | $0.78 |
| 2018-06-30 | $0.93 |
| 2018-03-31 | $0.60 |
| 2017-12-31 | $0.33 |
| 2017-09-30 | $1.11 |
| 2017-06-30 | $1.29 |
| 2017-03-31 | $0.93 |
| 2016-12-31 | $0.93 |
| 2016-09-30 | $0.69 |
| 2016-06-30 | $0.96 |
| 2016-03-31 | $0.54 |
| 2015-12-31 | $1.05 |
| 2015-09-30 | $0.45 |
| 2015-06-30 | $1.26 |
| 2015-03-31 | $1.26 |
| 2014-12-31 | $2.04 |
| 2014-09-30 | $1.77 |
| 2014-06-30 | $4.59 |
| 2014-03-31 | $0.66 |
| 2013-12-31 | $0.99 |
| 2013-09-30 | $1.44 |
| 2013-06-30 | $1.56 |
| 2013-03-31 | $0.63 |
| 2012-12-31 | $0.90 |
| 2012-09-30 | $0.12 |
| 2012-06-30 | $0.21 |
| 2012-03-31 | $-3.99 |
| 2011-12-31 | $-1.08 |
| 2011-09-30 | $0.24 |
| 2011-06-30 | $0.69 |
| 2011-03-31 | $0.45 |
| 2010-12-31 | $0.60 |
| 2010-09-30 | $0.39 |
| 2010-06-30 | $0.15 |
| 2010-03-31 | $-0.03 |
| 2009-12-31 | $0.48 |
| 2009-09-30 | $0.39 |
| 2009-06-30 | $0.30 |
| 2009-03-31 | $0.48 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.646B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tempus AI (TEM) | United States | $11.978B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $6.055B | 188.82 |
| Hims & Hers Health (HIMS) | United States | $5.988B | 154.89 |
| Axonics (AXNX) | United States | $3.602B | 1762.00 |
| IRhythm Technologies (IRTC) | United States | $2.783B | 0.00 |
| Privia Health (PRVA) | United States | $2.736B | 228.00 |
| Omnicell (OMCL) | United States | $2.263B | 74.03 |
| Azenta (AZTA) | United States | $2.242B | 127.33 |
| 10x Genomics (TXG) | United States | $1.925B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.657B | 0.00 |
| Schrodinger (SDGR) | United States | $1.422B | 0.00 |
| Phreesia (PHR) | United States | $1.252B | 0.00 |
| Standard BioTools (LAB) | United States | $0.830B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.613B | 0.00 |
| Talkspace (TALK) | United States | $0.586B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.582B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.508B | 88.00 |
| Health Catalyst (HCAT) | United States | $0.506B | 0.00 |
| Pulmonx (LUNG) | United States | $0.298B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.248B | 0.00 |
| TruBridge (TBRG) | United States | $0.214B | 62.22 |
| P3 Health Partners (PIII) | United States | $0.142B | 0.00 |
| American Well (AMWL) | United States | $0.139B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.106B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.064B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.050B | 0.00 |
| Outset Medical (OM) | United States | $0.045B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| CareCloud (CCLD) | United States | $0.042B | 0.00 |
| Movano (MOVE) | United States | $0.028B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.013B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Syra Health (SYRA) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Zhongchao (ZCMD) | China | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |